Menu
Recruiting NCT06377592

Development and Accuracy Evaluation of Gram Staining Analysis AI

Observational Bacterial Infections

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Sample collection without intervention.
Who it may be relevant to
Registry conditions: Bacterial Infections. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Japan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The investigators use Gram-stained specimens provided from clinical settings to develop and evaluate the accuracy of Gram staining analysis AI

Interventions

  • Other Sample collection without intervention
    No Intervention

Primary outcome measures

  • Advanced level of blood culture Gram stain analysis AI accuracy [Time frame: Day1]
  • Ordinary level of blood culture Gram stain analysis AI accuracy [Time frame: Day1]

Eligibility criteria

Inclusion criteria

  • Patients in whom a Gram stain test was ordered

Exclusion criteria

  • No exclusion criteria

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

Japan · 1 center
  • Osaka University Hospital — Suita

Identifiers

NCT: NCT06377592 · G22396

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗